Profile
Matthew D.
Roe worked as a Senior Director of Business Development at Genzyme Pharmaceuticals, Inc. He then worked as the Chief Business Officer at Crescendo Biologics Ltd. and as a Principal at GSK Plc.
Later, he worked as the Head of Category Marketing at Abcam Plc.
Mr. Roe holds an undergraduate degree from Brunel University and an MBA from Warwick Business School.
Former positions of Matthew D. Roe
| Companies | Position | End |
|---|---|---|
| ABCAM PLC | Sales & Marketing | 31/12/2016 |
Crescendo Biologics Ltd.
Crescendo Biologics Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in the development of new medicines based on antibody fragment technology | Corporate Officer/Principal | - |
| GSK PLC | Corporate Officer/Principal | - |
Genzyme Pharmaceuticals, Inc.
Genzyme Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical materials and drug delivery technologies | Corporate Officer/Principal | - |
Training of Matthew D. Roe
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Warwick Business School
Warwick Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Brunel University
Brunel University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Abcam Plc
Abcam Plc BiotechnologyHealth Technology Produces and distributes research-grade antibodies and associated products | Health Technology |
GSK Plc
GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Genzyme Pharmaceuticals, Inc.
Genzyme Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical materials and drug delivery technologies | Health Technology |
Crescendo Biologics Ltd.
Crescendo Biologics Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in the development of new medicines based on antibody fragment technology | Commercial Services |
- Stock Market
- Insiders
- Matthew D. Roe
















